Crossmark

Integrated bioinformatics analysis and clinical validation identifies TNFSF14 and CD40 as novel biomarkers for chronic kidney disease progression and tubulointerstitial injury

Crossref DOI link: https://doi.org/10.1007/s11255-026-05138-9

Published Online: 2026-04-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gu, Xiameng

Lu, Yuqing

Sha, Haonan

Zhang, Hanlu

Chen, Hongxin

Qiu, Mengyue

Chen, Xiaolan
Funding

Funding for this research was provided by:

Science and Technology Project of Nantong City (JCZ20066)
License Information

Text and Data Mining valid from 2026-04-25

Version of Record valid from 2026-04-25
More Information

Article History

Received: 25 January 2026

Accepted: 9 April 2026

First Online: 25 April 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below